Download Infections - Basildon and Thurrock University Hospitals

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Staphylococcus aureus wikipedia , lookup

Infection wikipedia , lookup

Gastroenteritis wikipedia , lookup

Schistosomiasis wikipedia , lookup

Chickenpox wikipedia , lookup

Clostridium difficile infection wikipedia , lookup

Urinary tract infection wikipedia , lookup

Anaerobic infection wikipedia , lookup

Antibiotics wikipedia , lookup

Infection control wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Neonatal infection wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Transcript
INFECTIONS
5.1
ANTIBACTERIAL TREATMENT: GENERAL PRINCIPLES
N.B.
ƒ This list is not exhaustive and cannot cover every presentation of an
infectious disease; if an infection is not listed please seek advice from
microbiology.
ƒ Antimicrobial therapy may need to be modified, particularly in the
context of immunosuppression, MRSA carriage, prior antimicrobial
therapy or foreign travel.
ƒ If no improvement in the patient’s condition is seen within 48-72 hours,
contact microbiology for advice.
The reasons for the existence of these antimicrobial prescribing guidelines are
numerous. The Standing Medical Advisory Committee issued guidelines on the topic
of antimicrobial resistance in September 1998. The issues highlighted by this
committee and thus built into our guidelines were as follows:
ƒ
ƒ
ƒ
ƒ
ƒ
ƒ
Antibiotic use selects for resistant bacteria.
Resistant bacteria accumulate and spread
Resistance increase clinical complications, lengthens hospital stay and adds
cost
Development of new antibiotics is slow, expensive and cannot be guaranteed
With more resistance and few new antimicrobial agents, modern medicine is
threatened.
Antibiotic usage can result in antibiotic associated diarrhoea and Clostridium
difficile infection
5.1.1 Choosing antibiotics
In choosing an appropriate antibiotic, the following factors must be considered:
ƒ Underlying pathology
ƒ Clinical presentation and site of infection
ƒ Micro-organisms involved (actual / suspected)
ƒ Patient characteristics
Allergy
Renal and hepatic function
Previous micro-organisms resistant to antibiotics
Females – pregnancy / breastfeeding
Concomitant drug therapies
Age
ƒ Duration of therapy, dose and route of administration – depends on site, type
and severity of infection, and response to treatment.
ƒ Intravenous therapy is required for life threatening infections. However, the risk
and expense of intravenous therapy should be avoided where possible.
Guidelines for appropriate conversion of intravenous to oral antibiotic treatment
are detailed overleaf.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 1 of 22
INFECTIONS
5.1.2 Prescribing
Indication
ƒ
The indication for treatment must be documented on the drug chart and in the
patient’s notes.
ƒ
Where this is considered inappropriate due to patient confidentiality, indication
must still be recorded in the notes. In this case “Refer to notes” should be written
in the Indication / additional information section of the drug chart.
Duration
ƒ
Duration of prescription should always be documented on the drug chart and in the
patient’s notes.
ƒ
Pharmacists will cross off the antimicrobial once the prescription is complete.
ƒ
Nurses should not administer any medication once the prescribed duration has
been exceeded, as this is no longer a valid prescription.
5.1.3 Patient Counselling
Inpatients
Patients or their legal guardians should be informed:
ƒ that an antimicrobial agent has been prescribed, and the reason why it is
necessary
ƒ Risks and side effects explained
At discharge
Patients or their legal guardians should be informed:
ƒ they have been prescribed an antimicrobial to take home and the reason why an
antimicrobial is necessary
ƒ the course length and the importance of completing the course
ƒ possible risks and side effects of the antimicrobial therapy, and what to do if they
develop at home
5.1.4 Automatic STOP Orders
Pharmacists will attach “automatic STOP order” stickers to prescriptions for oral
Antibiotics where appropriate to prevent administration for longer than 7 days.
If the doctor requires treatment to be continued for longer than 7 days, he/she must
rewrite the prescription.
Automatic STOP order stickers will not be attached for the treatment conditions, which
require prolonged antibacterial therapy, such as Tuberculosis, sub-acute Bacterial
Endocarditis and Osteomyelitis.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 2 of 22
INFECTIONS
5.2
IV TO ORAL ANTIMICROBIAL THERAPY SWITCH POLICY
Introduction
IV to oral switch is the punctual conversion of IV antibiotic therapy to an effective oral
dose. Patients may be considered for switching IV to oral therapy once the patient
has shown clinical improvement and medically stable.
Patients who present with a severe infection and initially require IV therapy can be
switched to oral therapy within 48 hours, provided that the patient is adequately
absorbing oral medication. Studies have shown that there a number of advantages to
support the IV to oral switch.
ƒ
ƒ
ƒ
ƒ
ƒ
ƒ
ƒ
Reduced risk of hospital acquired bacteraemia and infected IV lines
Saves both medical and nursing time
Reduces discomfort for patients
Facilitates possible discharge from hospital earlier
Possible cost reduction
Patient is more likely to receive antibiotics at correct time
Reduced risk of administration errors
The acronym COMS (see below for details) provides advice whether a patient is
suitable to be converted to oral therapy.
When to switch?
Considerations for the early switch to oral therapy COMS 1, 2, 3, 4 Patient should be
reviewed at 24 – 48 hours
C
Clinical improvement observed
O
Oral route not compromised (vomiting, malabsorptive disorder, NBM,
swallowing difficulties, unconscious, severe diarrhoea) NB: if NG/PEG feeding
then please consult your pharmacist.
M
Markers showing a trend towards normal
ƒ Apyrexial: Temp > 36oC and <38oC for at least 24 hours
ƒ BP stable
Plus NOT more than one of:
ƒ Heart rate >90 beats/min
ƒ Respiratory rate >20 breaths/min
ƒ WCC <4 or >12 (WCC should show a trend towards normal: absence of
such should not hinder switch if all other criteria met and not neutropenic
S
Specific indication/deep-seated infection (refer to table 1)
High risk/deep-seated infections
Certain infections may appear to respond rapidly to intravenous therapy, but
sometimes they require persistent IV therapy. This assures that sufficient drug levels
are attained at the site of infection and to optimise the response and prevent relapse.
Discuss with microbiology before switching patients with high risk/deep seated
infections to oral therapy.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 3 of 22
INFECTIONS
Table 1
Deep seated infections that may require High risk infections requiring prolonged
an initial two weeks of IV therapy
IV therapy
ƒ Liver abscess
ƒ Staphylococcus aureus bacteraemia
ƒ Osteomyelitis
ƒ Severe necrotising soft tissue infections
ƒ Septic Arthritis
ƒ Severe infections during chemotherapy
ƒ Empyema
related neutropaenia
ƒ Cavitating pneumonia
ƒ Infected implants/prosthesis
ƒ Meningitis/encephalitis
ƒ Intracranial abscesses
ƒ Mediastinitis
ƒ Endocarditis
ƒ Exacerbation of cystic fibrosis /
bronchiectasis
ƒ Inadequately drained abscesses or
empyema
ƒ Candidaemia
If you have any queries please contact Microbiology.
Pharmacists IV to oral antibiotic switch policy:
Pharmacists within Basildon and Thurrock University Hospitals NHS Foundation Trust have
the authority of the Medicines Management Committee to change intravenous antibiotics to
oral. This must in accordance with the above guidelines, and only where appropriate.
Documentation in the patients’ notes will bring this to the attention of the medical / surgical
team.
5.3
ANTIBIOTIC INTRAVENOUS TO ORAL CONVERSION GUIDELINES
Intravenous
Amoxicillin
Flucloxacillin
Benzylpenicillin
Clarithromycin
Co-amoxiclav
Metronidazole
Piptazobactam (Tazocin®), Vancomycin,
Meropenem, Gentamicin, Teicoplanin
Oral
Amoxicillin 500mg-1g TDS
Flucloxacillin 500mg – 1g QDS
Amoxicillin 500mg-1g TDS
Clarithromycin 500mg BD
Co-amoxiclav 625mg TDS
Metronidazole 400mg TDS
Seek advice from Microbiology
Exemptions to these guidelines are for the Intensive Care Unit (ITU) and Neonatal
Intensive Care Unit (NICU).
5.4
CIRCUMSTANCES WHERE ANTIBIOTICS ARE OFTEN NOT REQUIRED
1.
2.
3.
4.
Venous leg ulcers
Pressure sores
Colonising flora in upper respiratory tract
Diarrhoeal disease
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 4 of 22
INFECTIONS
5.5
ANTIBIOTIC COMBINATIONS
Never use either of the following as a single agent:
ƒ Sodium fusidate
ƒ Rifampicin
Unnecessary combinations:
This applies to the majority of cases of infection. Some patients with serious or
complex infections which have failed previous therapy may require combinations.
Contact Microbiology.
Unnecessary Combination
Co-amoxiclav (Augmentin®) /
Piperacillin & tazobactam (Tazocin®)
plus Metronidazole
Benzylpenicillin plus Cephalosporin
Flucloxacillin plus Vancomycin
Cephalosporin plus Broad-spectrum
penicillin/ Quinolone
5.6
Rationale
The former covers anaerobes
adequately, except for Clostridium
difficile. (Metronidazole may be
added in exceptional circumstances).
For CNS infections, use culture
sensitivities to rationalise treatment as
soon as possible.
Cross off Flucloxacillin if MRSA
isolated. Vancomycin will cover
majority of pathogens covered by
Flucloxacillin
Unless indicated by microbiology
ALLERGIES
Hypersensitivity reactions are the common form of adverse events with penicillin.
There are 2 main types – immediate and delayed.
Severe Allergy (Immediate reactions) – These result in a patient suffering from
anaphylaxis, angioedema or an immediate type of urticarial rash. Patients who suffer
from severe allergies should avoid all penicillins, cephalosporins and carbapenems.
Mild Allergy (Delayed reactions) – These result in the patient suffering from a rash,
which sometimes can appear 7-10 days after therapy. Patients who suffer mild
allergies should avoid pencillins. Cephalosporins and carbapenems can be used but
caution should be exercised because of cross-sensitivity.
Penicillin allergy
•
True anaphylactic penicillin allergy is rare.
•
Approximately 10% of patients who develop a rash with penicillin will also
develop a similar reaction to cephalosporins. There is no increased risk of
anaphylaxis in this patient group.
•
Refer to table below for guidance. If in doubt contact pharmacy or
microbiology.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 5 of 22
INFECTIONS
Drug use in penicillin rash allergy
DO NOT USE
Amoxicillin
Benzylpenicillin
Co-amoxiclav (Augmentin®)
Flucloxacillin
Penicillin v (Phenoxymethylpenicillin)
Piperacillin + Tazobactam (Tazocin®)
Temocillin
Ticarcillin + clavulanic acid (Timentin®)
Use with CAUTION
Aztreonam
Cefradine
Cefotaxime
Ceftazidime
Imipenem with Cilastatin (Primaxin®)
Meropenem
Can Use
Azithromycin
Doxycycline
Clarithromycin
Erythromycin
Minocycline
Gentamicin
Clindamycin
Sodium Fusidate
Vancomycin
Teicoplanin
Linezolid
Co-trimoxazole
Trimethoprim
Metronidazole
Ciprofloxacin
Nitrofurantoin
Antimicrobials that should not be used in true penicillin allergy are coloured red in this
formulary. Those that should be used with caution are orange.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 6 of 22
INFECTIONS
5.7
BLOOD: SEPTICAEMIA: “BLIND” TREATMENT OF INFECTION
Clinical features:
Fever, rigors, mental confusion, tachycardia, and hypotension.
Action:
ƒ Take blood cultures before initiating antibiotics
ƒ Establish primary source of sepsis
ƒ Consider likely pathogens
ƒ Consider the patient’s underlying pathology
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Possible cause
Source unknown
Non-blanching rash
/ purpura present
Likely
micro-organisms
Escherichia coli,
Staphylococcus
aureus,
Streptococcus
pneumoniae
Antibiotics
Penicillin Allergy
Piperacillin +
Tazobactam
(Tazocin®) 4.5g
TDS IV +
Gentamicin 5mg/kg
stat
Neisseria
meningitidis
Ceftriaxone 2g IV
BD
Mild allergy Meropenem 1g TDS IV
+ Gentamicin 5mg/kg IV
OD
Severe allergy –
Ciprofloxacin 400mg IV
BD + Teicoplanin
400mg IV BD for 3
doses then 400mg IV
OD + Gentamicin
5mg/kg IV
Chloramphenicol 1g IV
QDS
Discuss all cases
with microbiology
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 7 of 22
INFECTIONS
5.8
BONE AND JOINT
Comments
ƒ A microbiological assessment should be attempted before commencement of
antibiotic therapy.
ƒ Therapy is likely to be prolonged – 6 weeks to 6 months (please state this on
drug chart / prescription)
ƒ MRSA likely.
ƒ Bone and Joint antibiotic therapy should only be given after a microbiological
cultures has been taken (joint fluid/blood cultures)
ƒ Review antibiotics when culture results are available
ƒ Please note that a separate policy is available for diabetic foot infections
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Antibiotics
Osteomyelitis
Septic Arthritis
Flucloxacillin 1-2g QDS
IV + Sodium Fusidate
500mg TDS PO
Benzylpenicillin 1.2g IV
QDS + Flucloxacillin 1g
IV QDS
Penicillin Allergy /
MRSA
Teicoplanin 400mg IV
BD for 3 doses then
400mg IV OD and
Sodium Fusidate 500mg
TDS PO
Add Gentamicin if
systemically unwell.
Allergy or MRSA –
Teicoplanin 400mg IV
BD for 3 doses then OD
+ Clindamycin 600mg IV
QDS
Consult microbiology if
patient ≥65
Comments
Duration if acute
42 days
Duration if chronic
90 days
Duration of at least
28 days
If adolescent septic
arthritis, or if
gonococcus is
suspected, add
Ceftriaxone 2g IV
OD and discuss
with microbiology.
Ensure
urethral/cervical
swabs are
obtained prior to
starting antibiotics
if gonococcus
suspected
Prosthetic Joint
Infection
Discontinue
clindamycin
immediately if
diarrhoea develops
and discuss with
microbiology
No empirical treatment is required unless patient acutely unwell. All cases
must be discussed with microbiology
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 8 of 22
INFECTIONS
5.9
CARDIOVASCULAR
Comments
ƒ Blood cultures are essential
ƒ 3 sets of blood cultures must be taken prior to initiation of therapy
ƒ All cases should be discussed with microbiology
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Endocarditis – Acute
presentation (Native
valve)
Prosthetic valve
(await cultures)
Sternal wound
infection (Mild)
Severe sternal
wound infection/
Mediastinitis
5.10
Antibiotics
Benzylpenicillin 1.2g
4 hourly IV +
Gentamicin 1mg/kg
IV TDS +
Flucloxacillin 2g IV
QDS
Vancomycin 1g IV
BD + Rifampicin 300600mg PO/IV BD +
Gentamicin 1mg/kg
IV TDS
Flucloxacillin 500mg1g PO QDS
Meropenem 1g TDS
IV + Teicoplanin
400mg IV BD for 3
doses then OD
Penicillin Allergy
Vancomycin 1g BD
IV plus Gentamicin
1mg/kg IV TDS
Comments
If presentation is
indolent
benzylpenicillin and
gentamicin should be
sufficient
Vancomycin and
gentamicin are both
nephrotoxic.
Monitoring is
essential
Clarithromycin
500mg PO BD
Anaphylaxis – refer
to microbiology
CENTRAL NERVOUS SYSTEM
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Community –
acquired
meningitis
All patients
Community –
acquired
meningitis
Antibiotics
Penicillin Allergy Comments
(Severe)
Ceftriaxone 2g Chloramphenicol
Routine administration of antiviral
IV BD
1g IV QDS
treatment to patients with pure
meningitis is not indicated. If there is
evidence of encephalitis or meningoencephalitis add Aciclovir 10mg/kg
TDS
Add
Contact
Amoxicillin 2g microbiology
Review treatment in light of CSF
4o IV
cultures and PCR results
Age >55,
pregnancy,
immunosuppre
ssed, if listeria
suspected
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 9 of 22
INFECTIONS
5.11
DENTAL / MAXFAX
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Dental abscess
5.12
Antibiotics
Co-amoxiclav 625mg
TDS
Penicillin Allergy
Clindamycin 300mg
QDS
Consult microbiology
if patient ≥65
Comments
Discontinue
clindamycin
immediately if
diarrhoea develops
and discuss with
microbiology
EAR, NOSE AND THROAT
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Antibiotics
Otitis Externa
Topical
Gentamicin
Topical
Ciprofloxacin if
Pseudomonas
isolated
Amoxicillin 1g
Clarithromycin
PO TDS
500mg PO BD
Ceftriaxone 2g
Contact micro
IV BD
Consult microbiology
Penicillin V
Clarithromycin
500mg PO QDS 500mg PO BD
Benzylpenicillin Clindamycin
1.2g IV QDS +
600mg IV
Metronidazole
QDS.
500mg IV TDS
Consult
microbiology if
patient ≥65
Otitis Media
Mastoiditis (acute)
Mastoiditis (chronic)
Mild suspected
bacterial sore throat
Pharangitis/tonsillitis
(in-patient)
Penicillin
Allergy
Comments
Severe infection / malignant
disease / diabetes /
immunosuppressed – contact
microbiology
Urgent ENT review needed
Discontinue clindamycin
immediately if diarrhoea develops
and discuss with microbiology
If paratonsillar abscess / Ludwigs
angina / Vincents angina
suspected discuss with
microbiology
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 10 of 22
INFECTIONS
5.13
EYE
Infection
Conjunctivitis
5.14
Antibiotic
Chloramphenicol eye
drops/ointment
GENITAL
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Acute Pelvic
inflammatory Disease
Antibiotic
Ceftriaxone 2g IV stat
+ Doxycyline 100mg
PO BD+ Metronidazole
400mg TDS PO
Penicillin Allergy
If severe penicillin
allergy discuss with
Microbiology.
NB. Gonococcal resistance is
increasing. Outpatient
treatment should be discussed
with GU Medicine/Microbiology
Treatment of retained
products of conception
Chorioamnitis
Co-amoxiclav 625mg
TDS PO
Co-amoxiclav 1.2g
TDS IV
Consult microbiology
Mild allergy Ceftriaxone 2g IV OD
+ Metronidazole
500mg IV TDS
Severe allergy –
Ciprofloxacin 400mg
IV BD + Clindamycin
600mg IV QDS
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 11 of 22
Comments
Total duration 14
days
INFECTIONS
5.15
GASTROINTESTINAL
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Category
Antibiotic
Acute
Gastroenteritis
Mild
Usually none
required as selflimiting
Send stool sample
and await cultures
Co-amoxiclav
1.2g IV TDS ±
Gentamicin
5mg/kg stat
Moderate –
severe
Biliary tract
Infections,
pancreatitis, liver
abscess,
cholescysitis,
peritonitis,
diverticulitis,
bowel
perforation,
appendicitis,
peri-anal
abscess
Cholangitis,
previous ERCP
or stent insertion,
hospital acquired
intra-abdominal
sepsis
Helicobacter
pylori Eradication
Pancreatitis
Penicillin
Allergy
Comments
If antibiotics
required
discuss with
microbiology
Metronidazole
500mg IV TDS +
Ciprofloxacin
400mg IV BD ±
Gentamicin
5mg/kg IV OD∗
Tazocin® 4.5g IV
TDS +/Gentamicin
5mg/kg stat
Total duration
7-14 days
Identify and
eliminate
source; drain
any collection
Metronidazole
500mg IV TDS +
Ciprofloxacin
400mg IV BD ±
Gentamicin
5mg/kg IV OD∗
Amoxicillin 1g BD Metronidazole
+ Clarithromycin
400mg BD +
500mg BD +
Clarithromycin
Lansoprazole
500mg BD +
30mg BD for 7/7
Lansoprazole
30mg BD for 7/7
Antimicrobial therapy not routinely indicated, but may be required in
complicated / severe cases e.g. necrosis. Discuss with microbiology /
gastroenterology.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 12 of 22
INFECTIONS
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Clostridium
difficile
Category
First presentation
Second presentation
/ failed
Metronidazole (no
improvement after 3
days treatment)
∗
Antibiotic
Metronidazole
400mg PO TDS
Vancomycin
125mg PO QDS
Comments
Treatment required for at least 1014 days.
If strict Nil by Mouth or Paralytic
Ileus, use Metronidazole 500mg IV
TDS. All symptomatic patients will
be reviewed at least weekly by the
multidisciplinary infection
prevention and control team
Refer to separate Once Daily Gentamicin guidelines for prescribing information
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 13 of 22
INFECTIONS
5.16
RESPIRATORY
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Bronchiectasis
Category
Antibiotics
Tazocin® 4.5g IV
TDS
Doxycycline
100mg BD PO
Pencillin Allergy
Comments
Ciprofloxacin 500mg
-750mg BD PO
Infective
No CxR
N/A
For 7 days.
exacerbation of
changes
If intolerant to
COPD
tetracyclines
amoxicillin can
be used
Community –
Mild
Amoxicillin 500mg Clarithromycin
For 5-7 days
acquired
(CURB-65
-1g PO TDS
500mg PO BD
depending on
Pneumonia
score 0-1)
response
CURB – 65
Moderate
Amoxicillin 500mg Clarithromycin
For 7-10 days
score
(CURB-65
-1g PO TDS AND 500mg PO BD
depending on
Confusion AMT
score 2)
Clarithromycin
response
≤8
500mg PO BD
Urea ≥ 7mmol/l
For 10-14 days.
Severe
Co-amoxiclav
Mild allergy
Respiratory Rate (CURB-65
1.2g IV TDS AND Meropenem 1g TDS Discuss with
≥ 30
microbiology
score 3-5)
Clarithromycin
or Ertapenem 1g
Blood pressure
500mg PO/IV BD OD + Clarithromycin
≤90/60
500mg PO BD
Age >65
Severe allergy
Teicoplanin 400mg
IV BD for 3 doses
then OD +
Clarithromycin
500mg PO BD
®
Hospital Patients
Tazocin 4.5g IV
For 5-7 days
Mild allergy
acquired
who have
TDS
Meropenem 1g TDS according to
pneumonia
been in >48
clinical response
Severy allergy
hours
Teicoplanin 400mg
N.B. Check MRSA
IV BD for 3 doses
status
then OD +
Gentamicin 5mg/kg
IV OD∗
Co-trimoxazole IV
Alternative
Pneumocystis
120mg/kg/day in
Clindamycin
jirovecii
2-4 divided doses
600mg QDS +
(Pneumocystis
Primaquine
carinii)
30mg OD.
Discuss with
microbiology/
respiratory
team.*
*Adjunctive Steroids (Prednisolone 40mg BD x5/7, then 20mg BD x5/7, then 20mg OD x11/7) are
recommended, at the initiation of treatment, for all patients with HIV associated Pneumocystis and a PaO2 <
9.3 kPa (70mmHg) on air. For those patients with non-HIV related Pneumocystis, the benefit of steroids is less
certain but use should be considered on a case by case basis.
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 14 of 22
INFECTIONS
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Category
Aspiration
Pneumonia
(Hospital
acquired)
Empyema/Lung
abcess
Cystic Fibrosis
Tuberculosis
∗
Pencillin
Allergy
Levofloxacin
500mg IV BD
Legionella
pneumophilia
Aspiration
Pneumonia
(Community
acquired)
Antibiotics
Mild – moderate
(oral treatment)
Severe
(intravenous
treatment)
Amoxicillin
500mg PO / IV
TDS +
Metronidazole
400mg PO / IV
TDS
Tazocin® 4.5g IV
TDS
Comments
If severe add
rifampicin after
discussing with
microbiology
Most cases of
aspiration
pneumonia
cause a
chemical
pneumonitis
rather than
infection
Clarithromycin
500mg PO / IV
BD +
Metronidazole
400mg PO /
500mg IV TDS
Mild allergy
Meropenem 1g
TDS
Severe allergy
Teicoplanin
400mg IV BD for
3 doses then OD
+ Gentamicin
5mg/kg IV OD∗
Co-amoxiclav
NB. Review
Mild allergy
1.2g IV TDS
Meropenem 1g
prescription
IV TDS
once culture and
sensitivity
Severe allergy
Teicoplanin
results available
400mg IV BD for
3 doses then OD
+ Metronidazole
400mg PO TDS
+ Ciprofloxacin
500mg – 750mg
PO BD
Consult Respiratory Team
Consult Microbiology/Respiratory Team
Refer to separate Once Daily Gentamicin guidelines for prescribing information
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 15 of 22
INFECTIONS
5.17
URINARY TRACT
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Antibiotic
Uncomplicated UTI
and cystitis
Nitrofurantoin
50 -100mg QDS PO
(not effective if
GFR<60ml/min)
Gentamicin 5mg/kg
OD IV∗
Pyelonephritis
Penicillin
Allergy/Alternative
Gentamicin 5mg/kg
OD IV∗
Comments
Consult microbiology
Review once results
of MSU / blood
culture available. If
susceptible change
to co-amoxiclav.
Catheter related
infection
Gentamicin 5mg/kg
OD IV∗
Urinary catheter
prophylaxis
Epididymitis orchitis
See prophylaxis section
Ciprofloxacin 500mg
PO BD (outpatient)
Tazocin® 4.5g IV
TDS (inpatient)
Prostatitis
∗
Consult microbiology
Mild allergy
Meropenem 1g IV
TDS
Severe allergy
Ciprofloxacin 500mg
PO BD
Ciprofloxacin 500mg
PO BD
Men – 7 days
Women – 3 days
14 days treatment
required
All urinary catheters
will become
colonised over time.
There is no indication
for treatment unless
the patient is
symptomatic.
Treat for 10-14 days
Must assess patient
for risk of sexually
transmitted disease –
treatment may need
to be modified
accordingly. Take
appropriate swabs
and discuss with
microbiology.
Urology only
Refer to separate Once Daily Gentamicin guidelines for prescribing information
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 16 of 22
INFECTIONS
5.18
ƒ
SKIN AND SOFT TISSUE
Always consider previous history of MRSA carriage or of carriage. Add teicoplanin
(400mg IV bd for the first three doses then od) to the regimen, and discuss with
microbiology.
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Mild infection
e.g. Boils,
folliculitis
Cellulitis
Necrotising
fasciitis
All cases
must be
discussed
with
microbiology
Urgent
surgical
referral
required
Pressure sores
Infestations Headlice
Infestations Scabies
∗
Category
Antibiotic
Flucloxacillin
500mg PO QDS
Penicillin Allergy
Clarithromycin
500mg PO BD
Comments
Benzylpenicillin
1.2g IV QDS +
Flucloxacillin 1g IV
QDS
Clindamycin 600mg
IV QDS
Discuss with
microbiology if
patent ≥65
ƒ
MRSA
Teicoplainin 400mg IV BD for 3 doses
then OD + Sodium Fusidate 500mg PO
TDS
Upper or
lower limb
Benzylpenicillin
2.4g IV 4o +
Clindamycin 1.2g
IV QDS
Discuss with
microbiology
Torso
Abdomen
Scrotum
Meropenem 1g IV
TDS ± Gentamicin
5mg/kg IV OD∗
Mild allergy
Meropenem 1g IV
TDS ± Gentamicin
5mg/kg IV OD∗
Severe allergy
Discuss with
microbiology
Uncomplicated:
Wound toilet only
Complicated:
Flucloxacillin
500mg PO QDS +
Metronidazole
400mg PO TDS
Malathion alcoholic
solution/ aqueous
liquid
Permethrin 5%
cream
Prolonged IV
therapy may be
required.
ƒ Discontinue
clindamycin
immediately if
diarrhoea
develops and
discuss with
microbiology
Discontinue
clindamycin
immediately if
diarrhoea develops
and discuss with
microbiology
Phenothrin alcoholic Repeated wet
solution/aqueous
combing with ‘nit
liquid
comb’ is most
effective treatment
Malathion 0.5%
Treat all household
liquid
members
Refer to separate Once Daily Gentamicin guidelines for prescribing information
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 17 of 22
INFECTIONS
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Wound
infections (post
surgical) or
venflonitis
Animal /
human bites
Category
Antibiotic
Flucloxacillin
500mg - 1g PO
QDS
Prophylaxis Co-amoxiclav
625mg PO TDS for
1 week
Treatment
of
established
infection
Co-amoxiclav 1.2g
IV tds
Penicillin Allergy
Clarithromycin
500mg PO BD
Comments
If severe discuss
with micro
Doxycycline 100mg
PO BD +
Metronidazole
400mg PO TDS for
1 week
Clindamycin 600mg
IV qds +
Ciprofloxacin
500mg–750mg PO
bd
Discuss with
microbiology if
patent ≥65
ƒ
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 18 of 22
ƒ
ƒ
Tetanus
vaccine also
needed (see
BNF for current
prescribing
details)
Consider rabies
if bitten abroad
Discontinue
clindamycin
immediately if
diarrhoea
develops and
discuss with
microbiology
INFECTIONS
5.19
ANTIBACTERIAL PROPHYLAXIS
Some key principles to consider
9 Antibiotics should be given when contamination of a wound is expected or when
operations on a contaminated site may lead to bacteraemia. The majority of
“clean” operations do not warrant prophylaxis. The exception is when prosthetic
material is to be implanted where the consequences of infection are grave.
9 Prophylactic regimens should be directed against the most relevant pathogens. It
is impossible to cover all organisms. Regimens that decrease the total number of
pathogens are usually sufficient.
9 Antibiotics are usually best given parenterally at the time of induction of
anaesthesia to ensure effective tissue levels during surgery when there is a
maximum risk of local contamination or dissemination.
9 There is no evidence that prolonged prophylaxis has any advantage over single
doses. Indeed, prolonged administration tends to lead to the emergence of
resistant organisms, superinfection, and is also expensive.
9 Prophylaxis is inappropriate if there is established infection (e.g. where there is
established peritonitis due to visceral perforations, or in an infected prosthesis).
Full courses of the appropriate antibiotics will be required.
9 Single dose prophylaxis is usually adequate, but in any event, therapy should not
exceed 24 hours
9 Additional doses of antibiotics should be given if there is major blood loss of
prolonged surgery
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 19 of 22
INFECTIONS
5.19.1 Surgical Prophylaxis
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Surgery
Category
Antibiotics
General Surgery
Gynaecological
Surgery
Vascular
Orthopaedic
Urology
procedures
including
nephrostomy
insertion and
manipulations
Mesh
Hernia
Repair
No prosthetic device
Penicillin
Allergy/MRSA
Co-amoxiclav 1.2g IV Gentamicin 2mg/kg IV
at induction
+ Metronidazole
500mg IV at induction
Co-amoxiclav 1.2g
Gentamicin 2mg/kg +
IV at induction
Clindamycin 600mg IV
at induction
Co-amoxiclav 1.2g IV Teicoplanin 800mg IV
at induction
+ Gentamicin 2mg/kg
IV at induction
No prophylaxis
required
Co-amoxiclav 1.2g IV Gentamicin 2mg/kg IV
at induction and for 2 + Teicoplanin 800mg
doses post-op
IV at induction.
Teicoplanin 800mg IV
12 hours post-op
Arthroplasty, NOF #,
ACL, long bone
nailing,
instrumentation of
joints involving
implants (e.g. any
ORIF), and any other
metal implants
Revision of hips/knees Teicoplanin 800mg IV
and Gentamicin
2mg/kg IV after
tissue sampling,
then Teicoplanin 800
mg at 12 and 24 hours
and then once daily.
Treatment to be
reviewed with culture
results/histology
Gentamicin 2mg/kg IV
stat
Severe Trauma & Prevention
Amputation
gangrene
of
Co-amoxiclav 1.2g IV Gentamicin 2mg/kg IV
at induction
+ Teicoplanin 400mg
IV at induction
gas Benzylpenicillin 1.2g
Discuss with
IV QDS +
microbiology
Metronidazole
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 20 of 22
INFECTIONS
5.19.2 Cardiothoracic Centre Surgical Prophylaxis
Procedure
Antibiotic choice 1
Antibiotic choice 2
MRSA negative and not
allergic to penicillins
MRSA positive or unknown or penicillin allergy or recent
or past infective endocarditis
any weight
CABG and
Valve sugery
Thoracic
surgery
bodyweight < 65kg
bodyweight > 65kg
Induction:
Flucloxacillin 1g IV +
Gentamicin 2mg/kg IV
Induction:
Vancomycin 1g IV +
Gentamicin 2mg/kg
Induction:
Vancomycin 1.5g IV +
Gentamicin 2mg/kg
Then:
Flucloxacillin 1g IV 6
hourly for four more
doses
Top-up on starting
CPB:
Vancomycin 500mg
IV
Top-up on starting
CPB:
Vancomycin 750mg
IV
12 hours after
previous dose:
Vancomycin 1g IV
12 hours after
previous dose:
Vancomycin 1.5g IV
Induction:
Co-amoxiclav 1.2g IV
Induction:
Induction:
Vancomycin 1g IV +
Vancomycin 1.5g IV +
Gentamicin 2mg/kg IV Gentamicin 2mg/kg IV
Then:
Co-amoxiclav 1.2g IV 8
hourly for 2 more doses
12 hours after
induction:
Vancomycin 1g IV
12 hours after
induction:
Vancomycin 1.5g IV
5.19.3 Urinary Catheter Prophylaxis
Procedure
Catheter
insertion
Catheter
manipulation
Indicated
ƒ Obstructive uropathy
ƒ Patients with prosthetic joints or
vascular grafts
ƒ Manipulation of blocked catheters e.g.
bladder washouts
Manipulation of blocked catheters e.g.
bladder washouts
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 21 of 22
Antibiotic
Gentamicin 80mg IV / IM
stat
Gentamicin 80mg IV / IM
stat
INFECTIONS
5.19.4 Medical Prophylaxis
NB. All doses assume normal renal and hepatic function and are via the oral route unless
otherwise specified
Infection
Haemophilus
Influenzae
Neisseria
meningitidis
Splenectomy
Antibiotic
Rifampicin 600mg OD
PO
Child over 3 months:
20mg/kg OD PO (max.
600mg daily)
Ciprofloxacin:
Adults and children over
12 years 500 mg stat
Children aged 5–12
years 250 mg stat
Children 1 month–4
years 125 mg stat
Penicillin V 500mg PO
BD
2nd Choice
Comments
For 4 days
Rifampicin PO BD for 2
days:
ƒ Adults and children
over 12 years of age
600 mg
ƒ Children aged 1–12
years 10 mg/kg
ƒ Infants (under 12
months of age) 5
mg/kg
Suitable doses in children
based on average weight
for age are:
ƒ 0–2 months 20 mg (l
ml*)
ƒ 3–11 months 40 mg (2
ml*)
ƒ 1–2 years 100 mg (5
ml*)
ƒ 3–4 years 150 mg (7.5
ml*)
ƒ 5–6 years 200 mg (10
ml*)
ƒ 7–12 years 300 mg
(as capsule/or syrup)
Erythromycin 500mg PO
Ensure the following
BD
vaccines are given
-Menitorix +
Pneumovax
5.19.5 Endocarditis Prophylaxis
In March 2008 NICE reviewed the use of antibiotic prophylaxis for preventing endocarditis in
patients who are high-risk. They have advised against using antibiotic prophylaxis for the
prevention of infective endocarditis
If a clinician requires that a patient still receives antibiotic cover for any procedure, it is their
responsibility to ensure appropriate cover for the likely infecting organisms is given. Each
case should be discussed with microbiology.
July 2012
5.6 Allergies: hypersensitivity reaction; severe (immediate) – anaphylaxis and delayed – rash
Page 22 of 22